Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Pharmaceutical industry leaders, under the aegis of Association of Industrial Pharmacists of Nigeria (NAIP), have raised ...

Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Net Sales at Rs 949.42 crore in December 2024 up 17.9% from Rs. 805.26 crore in December 2023. Quarterly Net Profit at Rs.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

The medicines - known as dopamine agonists - are offered on the NHS and interact with parts of the brain that control ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...